The Max Foundation (Max) has announced that three patients have started treatment for HER2 negative/HR positive advanced breast cancer (ABC) including CDK4/6 inhibitor therapy in Mozambique through its Max Access Solutions programme.
Trending
- Otti signs Abia rehabilitation centre bill into law
- Misinformation, hate speech threaten governance, democratic stability — CDD
- Innovative Biotech CEO calls for reforms to boost Nigeria’s pharmaceutical sector
- ECOWAS pushes integrated, data-driven strategy to eliminate malaria in West Africa
- Air pollution raises cancer risk by 11%, global report warns
- CBN, NCC sign pact to boost consumer protection, tackle fraud
- Katsina launches 2026 subsidised fertiliser programme
- Osinbajo inaugurates Bayelsa road, hospital projects
